Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Magnetic Resonance Fingerprinting for Characterization of Brain Tumors After Radiotherapy

NCT06101069 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT06101069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06101069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Magnetic Resonance Fingerprinting for Characterization of Brain Tumors After Radiotherapy
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 14, 2024
Completion date
September 30, 2026
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, brain necrosis, brain tumor, glioma